These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8936709)

  • 41. Hypnotic susceptibility: multidimensional relationships with Cloninger's Tridimensional Personality Questionnaire, COMT polymorphisms, absorption, and attentional characteristics.
    Lichtenberg P; Bachner-Melman R; Ebstein RP; Crawford HJ
    Int J Clin Exp Hypn; 2004 Jan; 52(1):47-72. PubMed ID: 14768969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trait factors, state effects, and hypnotizability.
    Kumar VK; Pekala RJ; Cummings J
    Int J Clin Exp Hypn; 1996 Jul; 44(3):232-49. PubMed ID: 8690535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Positive affect, negative affect, and negative effects during a phenomenological hypnotic assessment within a substance abuse population.
    Pekala RJ; Kumar VK; Maurer RL; Elliott-Carter N; Moon E; Mullen K
    Int J Clin Exp Hypn; 2009 Jan; 57(1):64-93. PubMed ID: 19031234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reliability and validity of the Ego and Discomfort Anxiety Inventory.
    Whiteman VL; Shorkey CT
    Psychol Rep; 1994 Aug; 75(1 Pt 2):384-6. PubMed ID: 7809312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of hypnotic processes and responsiveness in a clinical context.
    Spinhoven P; Vanderlinden J; ter Kuile MM; Linseen AC
    Int J Clin Exp Hypn; 1993 Jul; 41(3):210-24. PubMed ID: 8335420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Imagination Inventory and its correlates with imagery and hypnotizability.
    Siuta J
    Am J Clin Hypn; 1996 Oct; 39(2):115-25. PubMed ID: 8936712
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Stanford Hypnotic Susceptibility Scale, Form C: normative data of a Dutch student sample.
    Näring GW; Roelofs K; Hoogduin KA
    Int J Clin Exp Hypn; 2001 Apr; 49(2):139-45. PubMed ID: 11294117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absorption and hypnotizability: context effects reexamined.
    Nadon R; Hoyt IP; Register PA; Kihlstrom JF
    J Pers Soc Psychol; 1991 Jan; 60(1):144-53. PubMed ID: 1995834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The efficacy of the Waterloo-Stanford Group Scale of hypnotic susceptibility: form C.
    Moran TE; Kurtz RM; Strube MJ
    Am J Clin Hypn; 2002; 44(3-4):221-30. PubMed ID: 11799536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Binaural beat induced theta EEG activity and hypnotic susceptibility: contradictory results and technical considerations.
    Stevens L; Haga Z; Queen B; Brady B; Adams D; Gilbert J; Vaughan E; Leach C; Nockels P; McManus P
    Am J Clin Hypn; 2003 Apr; 45(4):295-309. PubMed ID: 12722933
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A note of caution on the Waterloo-Stanford Group Scale of hypnotic susceptibility: a brief communication.
    Cardeña E; Terhune DB
    Int J Clin Exp Hypn; 2009 Apr; 57(2):222-6. PubMed ID: 19234968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fear of loss of vigilance: development and preliminary validation of a self-report instrument.
    Tsao JC; Craske MG
    Depress Anxiety; 2003; 18(4):177-86. PubMed ID: 14661187
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The relationship between memory, suggestibility and hypnotic responsivity.
    Eisen ML
    Am J Clin Hypn; 1996 Oct; 39(2):126-37. PubMed ID: 8936713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Waterloo-Stanford Group C (WSGC) scale of hypnotic susceptibility: normative and comparative data.
    Bowers KS
    Int J Clin Exp Hypn; 1993 Jan; 41(1):35-46. PubMed ID: 8425774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
    Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
    Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of stage hypnosis on audience members and participants.
    MacKillop J; Jay Lynn S; Meyer E
    Int J Clin Exp Hypn; 2004 Jul; 52(3):313-29. PubMed ID: 15370360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypnotic susceptibility and dream characteristics.
    Zamore N; Barrett D
    Psychiatr J Univ Ott; 1989 Nov; 14(4):572-4. PubMed ID: 2813640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of the somatic response survey.
    McCroskery JH; Reihman J
    Psychol Rep; 1991 Jun; 68(3 Pt 2):1097-8. PubMed ID: 1924610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Spanos Attitudes Toward Hypnosis Questionnaire: psychometric characteristics and normative data.
    Milling LS
    Am J Clin Hypn; 2012 Jan; 54(3):202-12. PubMed ID: 22443023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of a confusion technique on hypnotic responsivity in low-susceptible subjects.
    Stanger T; Tucker CM; Morgan JI
    Am J Clin Hypn; 1996 Jan; 38(3):214-8. PubMed ID: 8712164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.